Life Sciences Market Research Report

Report Filter Reset All

Sort By Price

Published Date

Category

Clear All

Publishers

Clear All

Report Type

Continents

Clear All

Regions

Clear All

Countries

Clear All

Pharma & Healthcare

Global (United States, European Union and China) Ponatinib Market Research Report 2019-2025

Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (P...

$3,280.00 06 August, 2019 | QYResearch

Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–p...

Pharma & Healthcare

Global (United States, European Union and China) Sandostatin LAR Market Research Report 2019-2025

Octreotide (trade name Sandostatin, among others) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor ...

$3,280.00 06 August, 2019 | QYResearch

Octreotide (trade name Sandostatin, among others) is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent ...

Pharma & Healthcare

Global (United States, European Union and China) Adult Meal Replacement Market Research Report 2019-2025

In 2019, the market size of Adult Meal Replacement is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in C...

$3,280.00 06 August, 2019 | QYResearch

In 2019, the market size of Adult Meal Replacement is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; ...

Pharma & Healthcare

Global (United States, European Union and China) Asthma and COPD Drugs Market Research Report 2019-2025

Asthma is a chronic respiratory disease blocking the airways of lung because of inflammation, mucus production, tighten of muscles. Chronic Obstructive Pulmo...

$3,280.00 06 August, 2019 | QYResearch

Asthma is a chronic respiratory disease blocking the airways of lung because of inflammation, mucus production, tighten of muscles. Chronic Obstruc...

Pharma & Healthcare

Global (United States, European Union and China) Clarityne Market Research Report 2019-2025

Clarityne are drugs that alter histamine effects by decreasing the histamine levels or blocking the histamine receptors. Generally, the histamine 1 or H1 re...

$3,280.00 06 August, 2019 | QYResearch

Clarityne are drugs that alter histamine effects by decreasing the histamine levels or blocking the histamine receptors. Generally, the histamine ...

Pharma & Healthcare

Global (United States, European Union and China) Dementia Drugs Market Research Report 2019-2025

In 2019, the market size of Dementia Drugs is 13900 million US$ and it will reach 26500 million US$ in 2025, growing at a CAGR of 8.4% from 2019; while in Ch...

$3,280.00 06 August, 2019 | QYResearch

In 2019, the market size of Dementia Drugs is 13900 million US$ and it will reach 26500 million US$ in 2025, growing at a CAGR of 8.4% from 2019; w...

Pharma & Healthcare

Global (United States, European Union and China) Ebola Treatment Market Research Report 2019-2025

Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequ...

$3,280.00 06 August, 2019 | QYResearch

Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease w...

Pharma & Healthcare

Global (United States, European Union and China) Generic Sterile Injectable Market Research Report 2019-2025

The generic sterile injectable are FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the healthcare ...

$3,280.00 06 August, 2019 | QYResearch

The generic sterile injectable are FDA approved biologics that are used for the treatment of many diseases and disorders in the vast arena of the h...

Pharma & Healthcare

Global (United States, European Union and China) Tapentadol Market Research Report 2019-2025

Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesic properti...

$3,280.00 06 August, 2019 | QYResearch

Tapentadol is an analgesic with a dual mode of action as a norepinephrine reuptake inhibitor and an agonist of the mu-opioid receptor. Its analgesi...

Pharma & Healthcare

Global (United States, European Union and China) Acute Myeloid Leukemia Treatment Market Research Report 2019-2025

Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 1...

$3,280.00 06 August, 2019 | QYResearch

Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from ...